165 related articles for article (PubMed ID: 1699786)
1. Natural killer cell activity in monoclonal gammopathies: relation to disease activity.
Osterborg A; Nilsson B; Björkholm M; Holm G; Mellstedt H
Eur J Haematol; 1990 Sep; 45(3):153-7. PubMed ID: 1699786
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell frequency and function in patients with monoclonal gammopathies.
Famularo G; D'Ambrosio A; Quintieri F; Di Giovanni S; Parzanese I; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
J Clin Lab Immunol; 1992; 37(3):99-109. PubMed ID: 1285130
[TBL] [Abstract][Full Text] [Related]
3. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).
Van Camp B; Durie BG; Spier C; De Waele M; Van Riet I; Vela E; Frutiger Y; Richter L; Grogan TM
Blood; 1990 Jul; 76(2):377-82. PubMed ID: 1695113
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.
Nishikawa K; Saito S; Morii T; Hamada K; Ako H; Narita N; Ichijo M; Kurahayashi M; Sugamura K
Int Immunol; 1991 Aug; 3(8):743-50. PubMed ID: 1716974
[TBL] [Abstract][Full Text] [Related]
5. Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications.
García-Sanz R; González M; Orfão A; Moro MJ; Hernández JM; Borrego D; Carnero M; Casanova F; Bárez A; Jiménez R; Portero JA; San Miguel JF
Br J Haematol; 1996 Apr; 93(1):81-8. PubMed ID: 8611480
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-induced down-modulation of CD16 and CD56 antigens on human natural killer cells and its regulation by histamine H2-receptors.
Hellstrand K; Kjellson B; Hermodsson S
Cell Immunol; 1991 Nov; 138(1):44-54. PubMed ID: 1717164
[TBL] [Abstract][Full Text] [Related]
7. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
[TBL] [Abstract][Full Text] [Related]
8. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
[TBL] [Abstract][Full Text] [Related]
9. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
10. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
[TBL] [Abstract][Full Text] [Related]
11. Two different maturational stages of natural killer lymphocytes in human newborn infants.
Sancho L; de la Hera A; Casas J; Vaquer S; Martínez C; Alvarez-Mon M
J Pediatr; 1991 Sep; 119(3):446-54. PubMed ID: 1715396
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
[TBL] [Abstract][Full Text] [Related]
13. B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS).
Büchi G; Girotto M; Termine G; Gario S; Grosso E; Autino R; Zappalà C
Pathologica; 1985; 77(1050):385-93. PubMed ID: 3879633
[No Abstract] [Full Text] [Related]
14. Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
Kantor TV; Whiteside TL; Friberg D; Buckingham RB; Medsger TA
Arthritis Rheum; 1992 Jun; 35(6):694-9. PubMed ID: 1376124
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine markers expressed by human natural killer (NK) cells are also detectable on human small cell carcinomas, neuroblastomas, and sea urchin coelomocytes.
Koros AM
Int J Neurosci; 1990 Apr; 51(3-4):255-6. PubMed ID: 1703997
[No Abstract] [Full Text] [Related]
16. [Characterization of peripheral blood natural killer (NK) cells in two patients with CD16+ CD56- NK cell-lineage granular lymphocyte-proliferative disorder].
Egashira M; Kaneko T; Oshimi K; Mizoguchi H; Ishida M
Rinsho Ketsueki; 1995 Feb; 36(2):69-75. PubMed ID: 7536278
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms accounting for the impaired natural-killer cell activity in refractory anaemia with excess of blasts.
Eliopoulos GD; Coulocheri SA; Eliopoulos AG; Katrinakis G; Karkavitsas N; Kyriakou D; Vaiopoulos G; Foudoulakis A
Eur J Haematol; 1992 May; 48(5):237-43. PubMed ID: 1379537
[TBL] [Abstract][Full Text] [Related]
18. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
19. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.
Mansour I; Doinel C; Rouger P
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of natural-killer-associated and activation antigens in multiple myeloma.
Gonzalez M; San Miguel JF; Gascon A; Moro MJ; Hernandez JM; Ortega F; Jimenez R; Guerras L; Romero M; Casanova F
Am J Hematol; 1992 Feb; 39(2):84-9. PubMed ID: 1550111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]